The groundbreaking therapy of tirzepatide peptide represents a significant development in the handling of type 2 diabetes. Distinct from existing therapies, tirzepatide targets multiple pathways – GLP-1 and GIP – https://tirzepatide-peptide622405.luwebs.com/42973298/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment